terça-feira, 21 de outubro, 2014

NOVARTIS ANALYZES WHAT WILL PRODUCE THE FACTORY OF PE

The future of company factory located in Jaboatão dos Guararapes, Pernambuco (PE), is being reviewed. The project was designed to produce recombinant proteins for a vaccine against meningitis B, however, with the recent acquisition of Novartis Vaccines by GlaxoSmithKline, the company is analyzing what will be produced in Pernambuco unit. "During this period, some investments and activities at the plant are on hold, which does not mean that the project will be discontinued, but will allow the correct setting in the configuration of the plant when we have more clarity of your targeting within the next few months," said the company in a statement. (Diário de Pernambuco)
Giro News - 21/10/2014
Produtos relacionados
Noticia traduzida automaticamente
clique AQUI para ver a original
Outras noticias
DATAMARK LTDA. © Copyright 1998-2024 ®All rights reserved.Av. Brig. Faria Lima,1993 3º andar 01452-001 São Paulo/SP